Total Payments
$969.45
2023 Payments
$25.06
Companies
26
Transactions
70
Medicare Patients
5,796
Medicare Billing
$534,210
Payment Breakdown by Category
Food & Beverage$969.45 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $969.45 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $169.87 | 11 | $0 (2020) |
| Amgen Inc. | $150.68 | 11 | $0 (2020) |
| Astellas Pharma US Inc | $72.04 | 6 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $69.87 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59.25 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $46.58 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $45.45 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $40.40 | 3 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $27.32 | 2 | $0 (2019) |
| Daiichi Sankyo Inc. | $27.13 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.06 | 1 | AstraZeneca Pharmaceuticals LP ($25.06) |
| 2020 | $102.47 | 7 | Novo Nordisk Inc ($24.51) |
| 2019 | $176.96 | 13 | Amgen Inc. ($61.92) |
| 2018 | $379.22 | 28 | Novo Nordisk Inc ($89.23) |
| 2017 | $285.74 | 21 | Novo Nordisk Inc ($40.09) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Respiratory | ||||||
| 03/16/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiovascular | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Diabetes | ||||||
| 02/21/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Neuroscience | ||||||
| 02/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: RESPIRATORY | ||||||
| 01/21/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Neuroscience | ||||||
| 10/29/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.04 | General |
| 10/22/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/19/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Endocrinology | ||||||
| 08/16/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Bone Health | ||||||
| 07/09/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/11/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Neuroscience | ||||||
| 06/04/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: UROLOGY | ||||||
| 05/22/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Bone Health | ||||||
| 04/23/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 01/25/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 01/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/14/2018 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: STRUCTURAL HEART | ||||||
| 11/26/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: UROLOGY | ||||||
| 11/15/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Virology & Specialty Care | ||||||
| 11/15/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,385 | 2,475 | $286,289 | $124,871 |
| 2022 | 18 | 1,362 | 3,967 | $330,003 | $153,416 |
| 2021 | 17 | 1,437 | 55,250 | $300,003 | $131,904 |
| 2020 | 20 | 1,612 | 88,248 | $299,978 | $124,019 |
Total Patients
5,796
Total Services
149,940
Medicare Billing
$534,210
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 760 | $145,446 | $62,182 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 209 | 209 | $48,770 | $25,616 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 140 | $18,225 | $8,336 | 45.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 88 | 90 | $10,350 | $6,801 | 65.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 263 | 627 | $10,032 | $5,252 | 52.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 23 | $6,774 | $3,398 | 50.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 24 | $6,202 | $3,294 | 53.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 93 | 95 | $3,420 | $2,717 | 79.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 40 | 102 | $3,876 | $1,672 | 43.1% |
| 77067 | Screening mammography | Office | 2023 | 14 | 14 | $2,450 | $1,194 | 48.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 17 | $1,317 | $668.11 | 50.7% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 36 | 36 | $6,993 | $642.30 | 9.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 37 | 37 | $8,186 | $554.88 | 6.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 41 | 124 | $4,233 | $520.80 | 12.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $466.20 | $400.40 | 85.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 55 | 58 | $4,717 | $328.28 | 7.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 19 | 20 | $1,090 | $325.85 | 29.9% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 14 | 14 | $603.40 | $310.80 | 51.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 33 | $1,484 | $294.87 | 19.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 20 | $524.80 | $280.80 | 53.5% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 16 | 18 | $1,130 | $82.44 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 256 | 571 | $104,268 | $48,678 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 522 | $63,375 | $28,716 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 214 | 214 | $46,098 | $26,788 | 58.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 1,440 | $55,800 | $24,570 | 44.0% |
About Dr. Roger Peck, MD
Dr. Roger Peck, MD is a Internal Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972570331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Peck, MD has received a total of $969.45 in payments from pharmaceutical and medical device companies, with $25.06 received in 2023. These payments were reported across 70 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($969.45).
As a Medicare-enrolled provider, Peck has provided services to 5,796 Medicare beneficiaries, totaling 149,940 services with total Medicare billing of $534,210. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Manhattan, KS
- Active Since 03/03/2006
- Last Updated 12/31/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972570331
Products in Payments
- Ozempic (Drug) $52.23
- PRALUENT ALIROCUMAB INJECTION (Biological) $51.76
- Aimovig (Biological) $49.44
- Prolia (Biological) $48.45
- Victoza (Drug) $47.75
- ENTRESTO (Drug) $45.45
- XARELTO (Drug) $40.40
- VESICARE (Drug) $38.59
- Saxenda (Drug) $37.50
- Repatha (Biological) $28.90
- LifeVest (Device) $27.32
- INJECTAFER (Drug) $27.13
- TRULICITY (Drug) $25.81
- FASENRA (Biological) $25.06
- Nucynta (Drug) $24.99
- STIOLTO RESPIMAT (Drug) $24.09
- EVENITY (Biological) $23.89
- Myrbetriq (Drug) $22.01
- FARXIGA (Drug) $21.52
- Vascepa (Drug) $20.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manhattan
Travis Koeneke, Md, MD
Internal Medicine — Payments: $21,792
Internal Medicine $21,792
Preeti Singh, Md, MD
Internal Medicine — Payments: $1,367
Internal Medicine $1,367
Mrs. Segen Elizabeth Chase, M.d, M.D
Internal Medicine — Payments: $712.51
Internal Medicine $712.51
Matthew Floersch, M.d, M.D
Internal Medicine — Payments: $587.18
Internal Medicine $587.18
Kenna Fischman, Md, MD
Internal Medicine — Payments: $572.14
Internal Medicine $572.14
Sara Stewart, Md, MD
Internal Medicine — Payments: $512.01
Internal Medicine $512.01